Regenerative medicine through stem cell technology is a source of hope for many suffering from ailments including Alzheimer’s disease, diabetes, spinal cord injury and cancer. While new therapeutic options are continually in development, progress has, until recently, been hampered by political and medical ethics arguments. Because of patient advocacy, new technologies are now advancing, from development of an artificial pancreas to the hope of culturing intact human organs. In this interview with The Life Sciences Report, Bernie Siegel, founder and executive director of the Genetics Policy Institute, describes recent progress and developments in the regenerative medicine universe.
- Could platelet-rich plasma injections help avoid knee surgery? More studies may give answer.
- An Experiment Using Human Stem Cells Ended Up Reversing Diabetes in Mice
- Stem Cell Therapy Reduces Need for Nearly 10% of Hip Replacements
- New therapy harnesses “dancing molecules” to reverse paralysis, repair tissue after spinal cord injuries
- Woman Hopes Father She’s Never Met Will Save Her Life by Donating Bone Marrow
- RNA Control Switch: Engineers Devise a Way To Selectively Turn On Gene Therapies in Human Cells
- Hoag trial spells hope for patients battling aggressive form of breast cancer
- Decades of research show common stem cells could fuel advances in regenerative medicine
- Nerve Repair with Help From Stem Cells
- Breakthrough within reach for diabetes scientist and patients nearest to his heart
- Neurona Therapeutics Receives IND Clearance to Initiate Phase 1/2 Clinical Trial of Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients
- Researcher awarded $12 million for a stem cell trial to improve outcomes of young blood cancer patients
- Stem cell therapy for kidney damage repair
- Takeda Receives Approval to Manufacture and Market Alofisel®▼ (darvadstrocel) in Japan for Treatment of Complex Perianal Fistulas in Patients with Non-active or Mildly Active Luminal Crohn’s Disease
- Repeated injury to airway stem cells could be major factor in chronic lung disease